Ocaña A - Search Results

1

Tonic-clonic seizure as the presentation symptom of severe hypocalcemia secondary to zoledronic acid administration.

Navarro M, López R, Alaña M, Ocaña A, Leno R, Sánchez F, Fonseca E, Cruz JJ. Navarro M, et al. Among authors: ocana a. J Palliat Med. 2007 Dec;10(6):1226-7. doi: 10.1089/jpm.2007.0113. J Palliat Med. 2007. PMID: 18095793 No abstract available.

2

New options in the treatment of locally advanced head and neck cancer: role for induction chemotherapy.

Cruz JJ, Ocaña A, Navarro M, Barco ED, Fonseca E. Cruz JJ, et al. Among authors: ocana a. Cancer Treat Rev. 2008 May;34(3):268-74. doi: 10.1016/j.ctrv.2007.12.004. Epub 2008 Jan 14. Cancer Treat Rev. 2008. PMID: 18194842 Review.

3

Third nerve palsy as the initial presenting sign of metastatic prostate cancer.

Navarro M, Ocaña A, Alañá M, Blanco O, Castro E, Fonseca E, Cruz JJ. Navarro M, et al. Among authors: ocana a. Am J Clin Oncol. 2008 Aug;31(4):407-8. doi: 10.1097/01.coc.0000217590.98344.54. Am J Clin Oncol. 2008. PMID: 18846004 No abstract available.

4

Integrating trastuzumab in the treatment of breast cancer. Current status and future trends.

Ocaña A, Rodríguez CA, Cruz JJ. Ocaña A, et al. Clin Transl Oncol. 2005 Apr;7(3):99-100. doi: 10.1007/BF02708741. Clin Transl Oncol. 2005. PMID: 15899216 Review. No abstract available.

5

Trastuzumab and antiestrogen therapy: focus on mechanisms of action and resistance.

Ocaña A, Cruz JJ, Pandiella A. Ocaña A, et al. Am J Clin Oncol. 2006 Feb;29(1):90-5. doi: 10.1097/01.coc.0000190274.00570.0a. Am J Clin Oncol. 2006. PMID: 16462510 Review.

6

Targeting receptor tyrosine kinases and their signal transduction routes in head and neck cancer.

Cruz JJ, Ocaña A, Del Barco E, Pandiella A. Cruz JJ, et al. Among authors: ocana a. Ann Oncol. 2007 Mar;18(3):421-30. doi: 10.1093/annonc/mdl175. Epub 2006 Jul 27. Ann Oncol. 2007. PMID: 16873430 Free article. Review.

7

Case 3. Upper limb lymphangiosarcoma following breast cancer therapy.

Ocaña A, Delgado C, Rodríguez CA, Bellido L, Izquierdo N, Martín R, Cruz JJ. Ocaña A, et al. J Clin Oncol. 2006 Mar 20;24(9):1477-8. doi: 10.1200/JCO.2005.01.8473. J Clin Oncol. 2006. PMID: 16549844 No abstract available.

8

Neuregulin expression modulates clinical response to trastuzumab in patients with metastatic breast cancer.

de Alava E, Ocaña A, Abad M, Montero JC, Esparís-Ogando A, Rodríguez CA, Otero AP, Hernández T, Cruz JJ, Pandiella A. de Alava E, et al. Among authors: ocana a. J Clin Oncol. 2007 Jul 1;25(19):2656-63. doi: 10.1200/JCO.2006.08.6850. J Clin Oncol. 2007. PMID: 17602072

9

Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer.

Chan M, Chang MC, González R, Lategan B, del Barco E, Vera-Badillo F, Quesada P, Goldstein R, Cruz I, Ocana A, Cruz JJ, Amir E. Chan M, et al. Among authors: ocana a. PLoS One. 2015 Jul 10;10(7):e0132449. doi: 10.1371/journal.pone.0132449. eCollection 2015. PLoS One. 2015. PMID: 26161666 Free PMC article.

10

Human recombinant erythropoietic agents do not induce changes in circulating levels of endoglin and vascular endothelial growth factor in anemic cancer patients.

Ocaña A, Rodríguez-Barbero A, Pericacho M, Bellido L, Seijas R, López R, Delgado C, de Prado DS, Cruz-Hernández JJ, López-Novoa JM. Ocaña A, et al. Cancer Lett. 2007 Sep 18;255(1):71-6. doi: 10.1016/j.canlet.2007.03.020. Epub 2007 May 4. Cancer Lett. 2007. PMID: 17482348

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters